From Phase I to Phase II: A Guide to Advancing Your NIH SBIR Research and Development Efforts

August 14, 2025 · 3 min read

Rachel Nguyen

Cover image

Introduction to Advancing Your NIH SBIR Research and Development Efforts

The National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program is a highly competitive funding opportunity for small businesses to engage in innovative research and development efforts. As a grant proposal writing instructor, I have seen many applicants struggle with the transition from Phase I to Phase II of the program. In this blog post, I will provide practical advice and best practices to help you successfully advance your NIH SBIR research and development efforts.

Understanding the Difference Between Phase I and Phase II

Before diving into the tips and best practices, it is crucial to understand the difference between Phase I and Phase II of the NIH SBIR program:

Phase I

Phase II

Best Practices for Advancing from Phase I to Phase II

1. Demonstrate Progress and Success in Phase I

To successfully advance to Phase II, it is essential to demonstrate the progress and success of your Phase I research and development efforts. This includes providing evidence of technical feasibility, proof-of-concept, and preliminary data that supports the potential for commercialization.

For example, if your Phase I project focused on developing a novel drug delivery system, you should provide data on the system's effectiveness in delivering the drug, its safety, and any preliminary results from animal studies or clinical trials.

2. Develop a Comprehensive Commercialization Plan

A strong commercialization plan is a key component of a successful Phase II proposal. This plan should include:

3. Assemble a Strong Team and Collaborators

The expertise and experience of your team and collaborators can significantly impact the success of your Phase II proposal. Be sure to:

4. Address Reviewer Feedback from Phase I

Incorporating reviewer feedback from your Phase I proposal can strengthen your Phase II application. Be sure to:

Conclusion

Successfully advancing from Phase I to Phase II of the NIH SBIR program requires a strong understanding of the program's objectives, a demonstration of progress and success in Phase I, and a well-developed commercialization plan. By following these best practices and seeking guidance from experienced grant proposal writing instructors, you can increase your chances of securing funding for your innovative research and development efforts.

Granted's AI coaching is built to help you navigate the Phase I-to-Phase II transition -- from presenting your feasibility data to building the detailed commercialization narrative reviewers expect. Learn how Granted supports SBIR applicants.

Keep Reading


Ready to find and win your next grant? Granted AI searches 85,000+ opportunities, analyzes your RFP, coaches you through each section, and runs AI committee review before you submit. Start free -- no credit card required.

Get AI Grants Delivered Weekly

New funding opportunities, deadline alerts, and grant writing tips every Tuesday.

Browse all SBIR grants

More SBIR Articles

The Department of War's Post-Reauthorization SBIR Suite Is Live, the ART Program Is the New Centerpiece, and CMMC Level 2 Is Now the Compliance Floor. What 90 Open Topics in 60 Days Tell You About the New Defense Innovation Pipeline.

Public Law 119-83 was signed April 13, 2026, reauthorizing SBIR/STTR through 2031. The Department of War issued its implementation announcement April 20 and released over 90 topics in six weeks. The new Accelerated Research for Transition (ART) Program restructures Phase II-to-acquisition transition, Strategic Breakthrough Awards offer $30M per project with 100% matching, and CMMC Level 2 self-assessment has been the compliance floor since November 10, 2025. Here is how to read the post-reauthorization DoW pipeline.

Read article

NIH's SBIR/STTR Program Closed Every Open NOFO on November 17. Reauthorization Was Signed April 13. Why the September 5 Standard Date Is the First Real Test of the Post-Freeze NIH Small Business Pipeline.

NOT-OD-26-006 closed all 23 NIH SBIR/STTR opportunities on Nov 17, 2025. The Small Business Innovation and Economic Security Act (S. 3971) was signed April 13, 2026, reauthorizing the program through 2031. NIH posted no active SBIR/STTR NOFOs through early June 2026 while it rebuilt its solicitation suite around new statutory requirements. The September 5 standard receipt date is the first real test of the post-freeze pipeline — here is what the unwind looks like and how to position for it.

Read article

DARPA's Microsystems Technology Office Just Released Six FY26 SBIR Topics Closing June 24 — From Nanopore Proteomics to 800°C Electronics. Why MTO Is the Quiet Heart of the Defense Innovation Pipeline.

DARPA MTO opened six FY26 SBIR topics on May 27 with a June 24 deadline — nanopore proteomics, compact RF filters, 800°C ICs, passive thermal spreaders, radiation-hardened codesign, and low-resource computing. The topics read like a wishlist for the next decade of contested-environment microelectronics. Here is what each one is actually asking for, and how small businesses should triage the four-week window.

Read article

Not sure which grants to apply for?

Use our free grant finder to search active federal funding opportunities by agency, eligibility, and deadline.

Find Grants

Ready to write your next grant?

Draft your proposal with Granted AI. Professional members win a grant in 12 months or get a full refund.

Backed by the Granted Guarantee